SAN DIEGO—With plans to advance 10 drugs into the clinic over the next five years for a variety of disorders, Entos Pharmaceuticals didn’t want to depend on contract manufacturers for the drug substance it will need to deliver those candidates.
So, earlier this year the Canadian-based genetic medicine developer opened a Good Manufacturing Practice (GMP) facility within its U.S. home base in the San Diego suburb of Carlsbad, CA.